N-/2-HYDROXY-3-(1-PIPERIDINYL) PROPOXY/PYRIDINE-1-OXIDE-3- CARBOXIMIDOYL CHLORIDE AND ITS USE IN THE TREATMENT OF INSULIN RESISTANCE
N-{2-hidroksi-3-(1-piperidinil)-propoksi}-piridin-1-oksid-3-karboksiimidoil hlorid, njegovi stereoizomeri, i adicione soli sa kiselinama. Prijava sadrži još 3 patentna zahteva. N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salt...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; srp |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | N-{2-hidroksi-3-(1-piperidinil)-propoksi}-piridin-1-oksid-3-karboksiimidoil hlorid, njegovi stereoizomeri, i adicione soli sa kiselinama. Prijava sadrži još 3 patentna zahteva.
N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes. |
---|